29 results
Thumbnail

D2. 259 - A Comprehensive Decision Algorithm for Hypersensitivity Reactions to Iodinated Contrast Media in a Tertiary Care Setting

Thumbnail

D2.255 - NSAID Hypersensitivity Records: Assessing Documentation Practice, Challenges, and Areas for Improvement

Thumbnail

D2.256 - Cytokine release reaction after subcutaneous daratumumab

Thumbnail

D2.246 - Anaphylaxis to sugammadex in a 15 year-old-girl

Thumbnail

D2.247 - Sensitization to Meloxicam, Celecoxib and Paracetamol in patients intolerant to non-steroidal antiinflamatory drugs (NSAIDS)

Thumbnail

D2.248 - Allergy to quinolones: a clinical case

Thumbnail

D2.249 - Application of Desensitization Protocol with Rituximab in the Treatment of Corticosteroid-Dependent Nephrotic Syndrome in an Adolescent

Thumbnail

D2.250 - Can drug allergy develop in x-linked agammaglobulinemia (xla)? case report

Thumbnail

D2.251 - Anaphylaxis due to Andrographis panniculata - an emerging problem

Thumbnail

D2.252 - Confirmation of selectivity pattern to Non-Steroidal Anti-inflammatory Drugs: a retrospective study in a Central Hospital

Thumbnail

D2.253 - Is it possible to treat DRESS without systemic corticosteroids?

Thumbnail

D2.254 - Can a medication leave its mark on the skin?

Thumbnail

D2.257 - Anaphylaxis with FOLFOX scheme: not everything is Oxaliplatin

Thumbnail

D2.258 - Fixed drug eruption caused by co-amoxiclav

Thumbnail

D3.48 - The delabeling of beta-lactam allergy does not change the antibiotic prescribing profile or alerts in Primary Care. The experience of a General Hospital

Thumbnail

D3.53 - A retrospective audit of NSAID hypersensitivity in children and young people in a tertiary paediatric allergy centre

Thumbnail

D3.55 - Synthetic folic acid allergy

Thumbnail

D3.47 - Implementing Penicillin Delabelling in an Inpatient setting

Thumbnail

D3.49 - Clinical significance and safety of provocation test for drug allergy diagnosis in outpatient unit: A real world observational study

Thumbnail

D3.50 - Penicillin-allergic labelled patients with a PEN-FAST score of 0 could safely be de-labelled by non-allergists